Study of MK 2206 in Patients With Relapsed or Refractory Diffuse Large B Cell Lymphoma

Update Il y a 4 ans
Reference: NCT01466868

Woman and Man

  • | Country :
  • France
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The purpose of this study is to evaluate the antitumor efficacy and the safety of MK 2206 in patients with relapsed or refractory diffuse large B cell lymphoma.


Inclusion criteria

  • Diffuse large B-cell lymphoma

Links